China National Accord Medicines Corp Ltd (000028) — Financial Flexibility Index
China National Accord Medicines Corp Ltd (000028) has a Financial Flexibility Index of -0.01x as of September 2025. Free cash flow of CN¥-366.47 Million (operating CF CN¥-425.23 Million minus capex CN¥58.77 Million) represents 0% of total liabilities (CN¥29.01 Billion). Check 000028 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
China National Accord Medicines Corp Ltd Financial Flexibility Index (1998–2024)
Historical Financial Flexibility Index trend for China National Accord Medicines Corp Ltd across 27 annual periods. For the full cash flow conversion analysis, see cash flow conversion of China National Accord Medicines Corp Ltd.
Annual Financial Flexibility Index for China National Accord Medicines Corp Ltd (1998–2024)
Year-by-year free cash flow to debt coverage for China National Accord Medicines Corp Ltd. Explore China National Accord Medicines Corp Ltd cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.13x | CN¥3.55 Billion | CN¥3.27 Billion | CN¥26.80 Billion | ▲ +8.2% |
| 2023 | 0.12x | CN¥3.26 Billion | CN¥2.94 Billion | CN¥26.59 Billion | ▼ -1.5% |
| 2022 | 0.12x | CN¥2.88 Billion | CN¥2.56 Billion | CN¥23.17 Billion | ▲ +52.1% |
| 2021 | 0.08x | CN¥2.03 Billion | CN¥1.66 Billion | CN¥24.76 Billion | ▲ +3.4% |
| 2020 | 0.08x | CN¥1.80 Billion | CN¥1.50 Billion | CN¥22.71 Billion | ▼ -36.0% |
| 2019 | 0.12x | CN¥2.25 Billion | CN¥2.00 Billion | CN¥18.16 Billion | ▲ +17.7% |
| 2018 | 0.11x | CN¥1.58 Billion | CN¥1.32 Billion | CN¥15.02 Billion | ▼ -12.5% |
| 2017 | 0.12x | CN¥1.49 Billion | CN¥1.29 Billion | CN¥12.42 Billion | ▼ -14.4% |
| 2016 | 0.14x | CN¥1.74 Billion | CN¥1.47 Billion | CN¥12.40 Billion | ▼ -13.4% |
| 2015 | 0.16x | CN¥1.24 Billion | CN¥1.05 Billion | CN¥7.65 Billion | ▲ +384.4% |
| 2014 | -0.06x | CN¥-454.03 Million | CN¥-796.70 Million | CN¥7.98 Billion | ▼ -180.8% |
| 2013 | 0.07x | CN¥615.52 Million | CN¥465.03 Million | CN¥8.74 Billion | ▲ +1.5% |
| 2012 | 0.07x | CN¥517.53 Million | CN¥323.96 Million | CN¥7.46 Billion | ▲ +1.6% |
| 2011 | 0.07x | CN¥426.29 Million | CN¥227.32 Million | CN¥6.24 Billion | ▼ -41.7% |
| 2010 | 0.12x | CN¥606.15 Million | CN¥428.16 Million | CN¥5.18 Billion | ▲ +36.5% |
| 2009 | 0.09x | CN¥373.78 Million | CN¥270.85 Million | CN¥4.36 Billion | ▼ -21.5% |
| 2008 | 0.11x | CN¥331.56 Million | CN¥246.58 Million | CN¥3.03 Billion | ▲ +64.0% |
| 2007 | 0.07x | CN¥159.11 Million | CN¥87.70 Million | CN¥2.39 Billion | ▼ -51.0% |
| 2006 | 0.14x | CN¥299.95 Million | CN¥181.73 Million | CN¥2.21 Billion | ▼ -53.6% |
| 2005 | 0.29x | CN¥198.90 Million | CN¥148.28 Million | CN¥678.73 Million | ▼ -1.0% |
| 2004 | 0.30x | CN¥144.48 Million | CN¥130.30 Million | CN¥487.99 Million | ▲ +50.9% |
| 2003 | 0.20x | CN¥130.58 Million | CN¥81.22 Million | CN¥665.47 Million | ▲ +153.1% |
| 2002 | 0.08x | CN¥55.66 Million | CN¥28.76 Million | CN¥717.90 Million | ▼ -45.4% |
| 2001 | 0.14x | CN¥107.06 Million | CN¥71.16 Million | CN¥753.72 Million | ▼ -58.7% |
| 2000 | 0.34x | CN¥29.53 Million | CN¥8.52 Million | CN¥85.83 Million | ▼ -40.8% |
| 1999 | 0.58x | CN¥50.38 Million | CN¥22.84 Million | CN¥86.72 Million | ▲ +325.2% |
| 1998 | 0.14x | CN¥15.59 Million | CN¥5.21 Million | CN¥114.11 Million | — |